← Leaderboards
Randall Espinoza
University Of California Los Angeles
$4,434,685
Attributed
$10,711,301
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2011–23$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,711,301 · 3
By mechanism
U01$5,525,791 · 1
R01$5,185,510 · 2
Top collaborators
- Katherine L Narr12 shared
- Danny Jiong Jiong Wang4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Katherine L Narr$12,999,877
- Agatha Lenartowicz$5,164,174
- David Sigmund Liebeskind$10,675,130
- Lonnie K Zeltzer$7,922,353
- Lutz Birnbaumer$1,910,878
Others in their field
Top investigators on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$297,689,086
- Lawrence Corey · Fred Hutchinson Cancer Center$297,689,086
- David R. Weir · University Of Michigan At Ann Arbor$286,732,935
- Jeffrey P Krischer · University Of South Florida$271,114,178
- David Heimbrook · Leidos Biomedical Research, Inc.$227,381,786
Research focus
Biological MarkersMagnetic Resonance ImagingResponseAntidepressive AgentsEffective TherapyElectroconvulsive TherapyBrainFunctional Magnetic Resonance ImagingBaseAnteriorClinical AssessmentsTreatment ResponseTreatment StrategyLinkGlutamatesHealth Care CostsStructureMental DepressionPerfusionHippocampus (Brain)Relating To Nervous SystemTreatment OutcomeCharacteristicsImage
Grant awards (12)
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$571,781
R01 · FY2023 · MH
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$585,901
R01 · FY2022 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,406,351
U01 · FY2019 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,363,539
U01 · FY2018 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,363,539
U01 · FY2017 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,392,362
U01 · FY2016 · MH
Imaging biomarkers of ECT response in major depressive disorder$918,328
R01 · FY2015 · MH
Imaging biomarkers of ECT response in major depressive disorder$974,291
R01 · FY2014 · MH
Imaging biomarkers of ECT response in major depressive disorder$552,905
R01 · FY2013 · MH
Imaging biomarkers of ECT response in major depressive disorder$398,353
R01 · FY2013 · MH
Imaging biomarkers of ECT response in major depressive disorder$575,942
R01 · FY2012 · MH
Imaging biomarkers of ECT response in major depressive disorder$608,009
R01 · FY2011 · MH